James Healy, Director at Karuna Therapeutics, Inc. (KRTX), bought 230,871 shares at $125.00 ($28.3M) on 2022-06-29, disclosed to the SEC on 2022-07-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.99 | 27,777 | $3.4M | 12.0% |
| 2 | $121.99 | 27,777 | $3.4M | 12.0% |
| 3 | $122.95 | 4,039 | $497K | 1.8% |
| 4 | $122.95 | 4,039 | $497K | 1.8% |
| 5 | $124.73 | 6,832 | $852K | 3.0% |
| 6 | $124.73 | 6,832 |
| $852K |
| 3.0% |
| 7 | $125.00 | 9,129 | $1.1M | 4.0% |
| 8 | $122.27 | 48,062 | $5.9M | 20.7% |
| 9 | $122.27 | 48,062 | $5.9M | 20.7% |
| 10 | $123.39 | 24,161 | $3.0M | 10.5% |
| 11 | $123.39 | 24,161 | $3.0M | 10.5% |
| Total | $122.71 avg | 230,871 | $28.3M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |